Inogen Inc Strategy Update Call Transcript
Hello, and welcome to Inogen's Strategy Update Conference Call. (Operator Instructions) As a reminder, this conference is being recorded today, February 27, 2023.
I would now like to turn the conference over to Nabil Shabshab, President and Chief Executive Officer. Please go ahead.
Thank you, Kevin. Good morning, everyone, to people here in the room as well as people that have joined us on the webcast. My name again is Nabil Shabshab, I'm the President and the CEO of Inogen. I've been with the company for just about 2 years now. So before I start talking about the transformation, which is on Slide 3, I just want to maybe provide some context for people that as earlier with Inogen very briefly. So we're a global med tech company with a footprint in about 60 countries where we commercialize our products.
Our revenue in 2022 was $377 million. The more important thing is we operate in a very difficult disease state, COPD. According to the CDC, the U.S. prevalence of COPD in 2020 was
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
